Skip to content

Hospital Innovation Programs Directory

An independent editorial resource published by Lisa T. Miller

Menu

Health system intelligence profile

Hackensack Meridian Center for Discovery and Innovation

Hackensack Meridian Health

Last reviewed August 30, 2026

Intelligence summary

Program at a Glance

Program mandate
The Center for Discovery and Innovation (CDI) is Hackensack Meridian Health's translational research center, which the system describes as an academic accelerator embedded inside a health care system rather than a conventional university institute. It opened on May 30, 2019 in a 250,000-square-foot facility on the 116-acre On3 campus in Nutley and Clifton, New Jersey, the former Hoffmann-La Roche site known as the birthplace of interferon.
Organizational model
Nonprofit
Location
Nutley, New Jersey
Program types
Innovation center
Commercialization pathways
InvestmentStrategic partnership
Focus areas
ClinicalDiagnosticsWorkforce
Public scale or maturity signals

Established 2019

Documented successes: Opened May 30, 2019 as a 250,000-square-foot research center on the former Hoffmann-La Roche campus in Nutley/Clifton, NJ, organized around three specialty institutes covering regenerative medicine, cancer and infectious disease, and multiple myeloma; founding board chaired by Celgene founder Sol J. Barer, Ph.D.

Official engagement route
Program website ↗Health system website ↗
Last reviewed
August 30, 2026

Mandate and remit

What This Program Does

The Center for Discovery and Innovation (CDI) is Hackensack Meridian Health's translational research center, which the system describes as an academic accelerator embedded inside a health care system rather than a conventional university institute. It opened on May 30, 2019 in a 250,000-square-foot facility on the 116-acre On3 campus in Nutley and Clifton, New Jersey, the former Hoffmann-La Roche site known as the birthplace of interferon. CDI runs on what it calls an agile, incentive-driven model, bringing researchers, practicing clinicians and life sciences companies together to develop new diagnostics, treatments and preventive strategies in cancer, infectious disease, immunology and behavioral and neurocognitive health. It is funded through a mix of federal grants from the NIH and National Cancer Institute, individual and corporate philanthropy, venture philanthropy and venture capital. Outside life sciences companies engage CDI as research collaborators and co-development partners, and the center also serves as the research hub for the adjacent Hackensack Meridian School of Medicine.

Areas of Focus

ClinicalDiagnosticsWorkforce

Commercialization Pathways

These routes appear in the program's sourced public record.

Publicly Reported Outcomes

  • Documented successes

    Opened May 30, 2019 as a 250,000-square-foot research center on the former Hoffmann-La Roche campus in Nutley/Clifton, NJ, organized around three specialty institutes covering regenerative medicine, cancer and infectious disease, and multiple myeloma; founding board chaired by Celgene founder Sol J. Barer, Ph.D.

Leadership and Structure

Organizational home: Hackensack Meridian Center for Discovery and Innovation, Hackensack Meridian Health

  • David S. Perlin, Ph.D.Chief Scientific Officer and Senior Vice President, Center for Discovery and Innovation

Contact the Program

Use the program's published contact route for partnership, licensing, innovation, or program inquiries.

Official contact page
Open contact page ↗

Related Programs

Comparable records based on shared public taxonomy, location, or commercialization route.

Same state · Same program type · Same commercialization route

New Brunswick, New Jersey

RWJBarnabas Health

Center for Innovation at Robert Wood Johnson University Hospital

The Center for Innovation opened on September 16, 2022 on the main campus of Robert Wood Johnson University Hospital in New Brunswick as a partnership between RWJUH and Rutgers Robert Wood Johnson Medical School.

Innovation centerInvestmentStrategic partnershipClinicalArtificial intelligenceMedical device

Nonprofit

Read the intelligence brief

Reviewed August 30, 2026

Same program type · Same commercialization route

Celebration, Florida

AdventHealth

AdventHealth Nicholson Center

The AdventHealth Nicholson Center is a 54,000-square-foot medical learning and simulation incubation center in Celebration, Florida, which AdventHealth describes as one of the nation's largest and most experienced facilities of its kind.

Innovation centerStrategic partnershipClinicalMedical device

Nonprofit

Read the intelligence brief

Reviewed August 30, 2026

Same program type · Same commercialization route

Charlotte, North Carolina

Advocate Health

Advocate Health Innovation (Innovative Collaborations and Technology Transfer Office)

Advocate Health's enterprise innovation function is led by a Chief Innovation and Commercialization Officer and combines an external-partnership front door with an internal commercialization office.

Innovation centerTechnology transferLicenseStrategic partnershipClinicalWorkforce

Nonprofit

Read the intelligence brief

Reviewed August 30, 2026

Same program type · Same commercialization route

Charlotte, North Carolina

Advocate Health (Atrium Health)

The Pearl

The Pearl is Advocate Health and Atrium Health's innovation district in Charlotte's historic Brooklyn neighborhood, launched June 2, 2025 in partnership with Wexford Science & Technology and Ventas.

Innovation centerInvestmentStrategic partnershipClinical

Nonprofit

Read the intelligence brief

Reviewed August 30, 2026

Same program type · Same commercialization route

Winston-Salem, North Carolina

Advocate Health (Wake Forest University School of Medicine / Atrium Health Wake Forest Baptist)

Center for Healthcare Innovation (CHI)

The Center for Healthcare Innovation is the implementation-focused innovation engine inside Atrium Health Wake Forest Baptist, built around the premise that it takes an average of 17 years to move medical discoveries into mainstream care and that the gap can be narrowed.

Innovation centerAcceleratorStrategic partnershipClinicalWorkforce

Academic · Nonprofit

Read the intelligence brief

Reviewed August 30, 2026

Same program type · Same commercialization route

Chicago, Illinois

Ann and Robert H. Lurie Children's Hospital of Chicago

Innovate2Impact (I2I) Program

Innovate2Impact is the innovation and intellectual property program of Lurie Children's and the Stanley Manne Children's Research Institute, created to bridge the gap between discovery and usable products and technologies.

Technology transferInnovation centerLicenseStrategic partnershipClinicalPediatricWorkforce

Children's · Nonprofit

Read the intelligence brief

Reviewed August 30, 2026

Sources and Updates

Reviewed August 30, 2026. External source links open in a new tab.

  1. Hackensack Meridian Center for Discovery and Innovation official source hmh-cdi.org. Accessed August 30, 2026.
  2. Hackensack Meridian Center for Discovery and Innovation source 2 prnewswire.com. Accessed August 30, 2026.
  3. Hackensack Meridian Center for Discovery and Innovation source 3 hmh-cdi.org. Accessed August 30, 2026.

Confidential comparison

How does your innovation program compare?

Request a confidential conversation about the commercial opportunities, market pathways, and capabilities within your hospital's innovation portfolio. The public directory does not score or rank programs.